5th Annual Cell and Gene Therapy Congress

5th Annual Cell and Gene Therapy Congress

Oxford Global 24/10/2019 to 25/10/2019 | United Kingdom, Hotel Novotel London West, Hammersmith International Ctre 1, Shortlands, London, W6 8DR
+44 1865 248455

We will welcome over 350 delegates representing leading biotechnology companies, global pharmaceutical organisations, and internationally renowned academic institutions.


Over 30 presentations, case studies and panel discussions focussed on Cell and Gene Therapy development and clinical research, the commercialisation of CAR T treatments, and Cell and Gene Therapy bioprocessing and manufacturing strategies.


3 interactive streams:


Day 1 Stream 1: Cell and Gene Therapy Development and Clinical Trials

Day 1 Stream 2: Cell and Gene Therapy Bioprocessing and Manufacturing Strategies

Day 2 Stream 1: Commercialising Cell and Gene Therapy Treatments

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.


Co-located with our highly anticipated 8th Annual Cell Culture and Bioprocessing Congress, 6th Annual Stem Cell and Regenerative Medicine Congress and 2nd Annual Biobanking Congress.



Tickets: https://go.evvnt.com/395618-2?pid=264

Brochure: https://go.evvnt.com/395618-3?pid=264


Time: 7:30 am - 5:00 pm



Registration Available from: GBP 299.0


Speakers: Axel Hoos, Senior Vice President and Oncology Therapeutic Area Head, GlaxoSmithKline, Peter Olagunju, Vice President, Patient Operations and Lentiglobin Program Leader, bluebird bio, David Gilham, Vice President, Research and Development, Celyad, Paul Lammers, President and Chief Executive Officer, Triumvira Therapeutics, Soraya Bekkali, Chief Executive Officer, Gyroscope Therapeutics

page up